ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $92,000 | -73.8% | 22,226 | -83.8% | 0.00% | – |
| Q2 2020 | $351,000 | +344.3% | 137,292 | +556.3% | 0.00% | – |
| Q4 2019 | $79,000 | -60.3% | 20,918 | -46.3% | 0.00% | – |
| Q3 2019 | $199,000 | -45.5% | 38,944 | -8.8% | 0.00% | -100.0% |
| Q4 2018 | $365,000 | +12.7% | 42,714 | +163.9% | 0.00% | 0.0% |
| Q3 2018 | $324,000 | +24.1% | 16,187 | +31.2% | 0.00% | 0.0% |
| Q3 2017 | $261,000 | +10.1% | 12,339 | -8.9% | 0.00% | 0.0% |
| Q2 2017 | $237,000 | +34.7% | 13,549 | +11.2% | 0.00% | 0.0% |
| Q1 2016 | $176,000 | -67.7% | 12,186 | -59.1% | 0.00% | -85.7% |
| Q2 2014 | $545,000 | – | 29,826 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |